Skip to Main Content

Paper Details

Genome-scale in vivo CRISPR screen identifies RNLS as a target for beta cell protection in type 1 diabetes.
Nat Metab
45
2020
Author NameAffiliation
Celia A SchifferUniversity of Massachusetts Medical School
Douglas A MeltonHarvard Stem Cell Institute, Harvard University
  • 1 - 2

Datasets

Release 1.2